SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹122 Cr | ₹176 Cr | ₹209 Cr | ₹154 Cr | ₹216 Cr |
What is the latest Total Non-Current Liabilities ratio of SEQUENT SCIENTIFIC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹122 Cr |
Mar2023 | ₹176 Cr |
Mar2022 | ₹209 Cr |
Mar2021 | ₹154 Cr |
Mar2020 | ₹216 Cr |
How is Total Non-Current Liabilities of SEQUENT SCIENTIFIC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹122 Cr | -30.56 | |
Mar2023 | ₹176 Cr | -15.92 | |
Mar2022 | ₹209 Cr | 36.16 | |
Mar2021 | ₹154 Cr | -29.05 | |
Mar2020 | ₹216 Cr | - |
Compare Total Non-Current Liabilities of peers of SEQUENT SCIENTIFIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SEQUENT SCIENTIFIC | ₹3,584.3 Cr | 4.8% | -4.9% | 20.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,908.0 Cr | 3.9% | 2.1% | 12% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,601.0 Cr | 3.6% | -1.6% | 66.9% | Stock Analytics | |
CIPLA | ₹122,197.0 Cr | 3.5% | 2.7% | 0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,314.0 Cr | 5.6% | 5% | 23.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,020.6 Cr | 7.1% | -1.1% | -6.8% | Stock Analytics |
SEQUENT SCIENTIFIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SEQUENT SCIENTIFIC | 4.8% |
-4.9% |
20.3% |
SENSEX | 3.1% |
0.5% |
4.5% |
You may also like the below Video Courses